The TGA has published their 2022-23 Advertising Compliance Report.

This report covers the 2022-23 financial year and includes information on the TGA advertising and supply compliance priorities 2022-23 (outlined in CMA’s 26 July 2022 tech alert), which include matters relating to:

- Unapproved performance and image enhancing products and sport supplements;

- Unapproved therapeutic goods associated with COVID-19;

- Advertising of therapeutic goods used in the cosmetic and beauty industry; and

- Advertising of unapproved goods on digital platforms.

The report details numbers of alleged advertising contraventions, TGA compliance assessment outcomes and actions, and the TGA’s approach to compliance education and enforcement.

Resources:

- TGA web page: Therapeutic Goods Advertising and Compliance Education Plan 2023

- TGA web page: Therapeutic Goods Advertising Compliance Education Strategy 2021 

- Therapeutic Goods (Therapeutic Goods Advertising Code) Instrument 2021

- TGA web page: How we manage Advertising Compliance

- CMA 26 July 2022 tech alert: TGA Compliance Priorities 2022-23: Import, Advertising and Supply including unapproved goods, e-commerce supply of unapproved goods; COVID-19 or serious diseases; sports supplements, medicinal cannabis